The extrahepatopancreatic ducts as a novel source of hepatic progenitors

肝胰外管作为肝祖细胞的新来源

基本信息

项目摘要

Project Summary While foregut endoderm research has primarily focused on the development and regeneration of the liver, pancreas, and intestine, relatively little attention have been placed on the nexus by which these organs are connected. The mammals and zebrafish the extrahepatopancreatic duct (EHPD) system functions as a tubular network joining the liver, pancreas, and gall bladder together with the duodenum. Extensive genetic and morphogenetic conservation between human and zebrafish EHPDs not only qualifies the zebrafish as a practical genetic model for this tissue, but also suggests more critical roles for the EHPDs beyond simply transporting hepatic bile and pancreatic enzymes. We propose here to leverage the zebrafish vertebrate model to rigorously explore the function of EHPD cells as a novel and significant source of progenitors for liver development, homeostasis, and regeneration. Using a zebrafish model that phenocopies hepatic biliary cell loss in Alagille Syndrome (ALGS), we found that agenesis of intrahepatic duct (IHD) cells, due to transient loss of the Notch ligand Jagged, can lead to a robust cellular response outside the liver, within the EHPD. Specifically, the EHPD cells react to the liver duct cell loss by proliferating excessively and contributing primarily to the regenerated IHD cells and hepatocytes also. These unexpected findings suggest that the EHPD system harbors multipotent progenitors that can contribute to the liver. Our discovery of multipotent progenitors residing in the EHPD leads to fundamental new questions: To what extent and by what mechanisms do the EHPD cells contribute to the liver during development, homeostasis, and regeneration? And how are these progenitors formed and maintained? We hypothesize that the EHPDs act as the initial source of nearly all progenitors for the liver. We posit that EHDP progenitors have high proliferative capacity and are maintained in an undifferentiated, quiescent state by FGF signaling. Further, we hypothesize that these EHPD cells are poised for expansion and migration to become distributed throughout the liver, ultimately adopting cholangiocyte or hepatocyte identity during development and homeostasis, and to a greater degree, in response to specific types of liver damage. Insufficient EHPD progenitors may lead to alternative mechanisms of regeneration such as transdifferentiation. Testing these hypotheses may lead to a unifying, dynamic liver regeneration model, whereby the availability of EHPDs progenitors is a significant determinant of which regenerative mechanism predominates. Uncovering a more fundamental role for the EHPD cells in liver regenerative biology will advance our understanding and treatment of liver diseases including ALGS and other cholangiopathies, as well as hepatocyte disorders. A central role for the EHPD in liver regeneration would also implicate it as a novel target tissue for liver therapies. We propose to investigate the lineage contribution of EHPD cells during liver development, homeostasis, and regeneration, and the genetic and cellular mechanisms driving this complex process.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

P. Duc Si Dong其他文献

P. Duc Si Dong的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('P. Duc Si Dong', 18)}}的其他基金

Augmented Notch signaling as a therapeutic approach for Alagille Syndrome
增强型 Notch 信号传导作为 Alagille 综合征的治疗方法
  • 批准号:
    10504974
  • 财政年份:
    2022
  • 资助金额:
    $ 42.9万
  • 项目类别:
Augmented Notch signaling as a therapeutic approach for Alagille Syndrome
增强型 Notch 信号传导作为 Alagille 综合征的治疗方法
  • 批准号:
    10672969
  • 财政年份:
    2022
  • 资助金额:
    $ 42.9万
  • 项目类别:
The extrahepatopancreatic ducts as a novel source of hepatic progenitors
肝胰外管作为肝祖细胞的新来源
  • 批准号:
    10466867
  • 财政年份:
    2020
  • 资助金额:
    $ 42.9万
  • 项目类别:
The extrahepatopancreatic ducts as a novel source of hepatic progenitors
肝胰外管作为肝祖细胞的新来源
  • 批准号:
    10053220
  • 财政年份:
    2020
  • 资助金额:
    $ 42.9万
  • 项目类别:
Unlocking Regenerative Potential through in Vivo Genetic Reprogramming
通过体内基因重编程释放再生潜力
  • 批准号:
    8358718
  • 财政年份:
    2012
  • 资助金额:
    $ 42.9万
  • 项目类别:

相似海外基金

Resolving Uncertainty in Alagille Syndrome Diagnostics
解决阿拉吉尔综合征诊断中的不确定性
  • 批准号:
    10734881
  • 财政年份:
    2023
  • 资助金额:
    $ 42.9万
  • 项目类别:
Augmented Notch signaling as a therapeutic approach for Alagille Syndrome
增强型 Notch 信号传导作为 Alagille 综合征的治疗方法
  • 批准号:
    10504974
  • 财政年份:
    2022
  • 资助金额:
    $ 42.9万
  • 项目类别:
Augmented Notch signaling as a therapeutic approach for Alagille Syndrome
增强型 Notch 信号传导作为 Alagille 综合征的治疗方法
  • 批准号:
    10672969
  • 财政年份:
    2022
  • 资助金额:
    $ 42.9万
  • 项目类别:
Alagille Syndrome Scientific Meeting - Measuring What Matters
阿拉吉尔综合症科学会议 - 衡量重要的事情
  • 批准号:
    10469076
  • 财政年份:
    2022
  • 资助金额:
    $ 42.9万
  • 项目类别:
Targeting POGLUT1 to promote biliary development in Alagille syndrome
靶向 POGLUT1 促进 Alagille 综合征胆道发育
  • 批准号:
    10449607
  • 财政年份:
    2022
  • 资助金额:
    $ 42.9万
  • 项目类别:
Molecular and cellular basis of the renal diseases associated with Alagille Syndrome
阿拉吉尔综合征相关肾脏疾病的分子和细胞基础
  • 批准号:
    10617239
  • 财政年份:
    2021
  • 资助金额:
    $ 42.9万
  • 项目类别:
Molecular and cellular basis of the renal diseases associated with Alagille Syndrome
阿拉吉尔综合征相关肾脏疾病的分子和细胞基础
  • 批准号:
    10209370
  • 财政年份:
    2021
  • 资助金额:
    $ 42.9万
  • 项目类别:
Molecular and cellular basis of the renal diseases associated with Alagille Syndrome
阿拉吉尔综合征相关肾脏疾病的分子和细胞基础
  • 批准号:
    10399602
  • 财政年份:
    2021
  • 资助金额:
    $ 42.9万
  • 项目类别:
Combined genetic analyses can achieve efficient diagnostic yields for subjects with Alagille syndrome
结合遗传分析可以对阿拉吉勒综合征受试者实现有效的诊断率
  • 批准号:
    17K11516
  • 财政年份:
    2017
  • 资助金额:
    $ 42.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Negative regulation of Jagged1 by glycosylation: towards a mechanism-based therapy for Alagille syndrome
糖基化对 Jagged1 的负调控:针对 Alagille 综合征的基于机制的治疗
  • 批准号:
    9310392
  • 财政年份:
    2016
  • 资助金额:
    $ 42.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了